Investor Overview Press Releases February 19, 2020 Aclaris Therapeutics to Announce Fourth Quarter and Full Year 2019 Financial Results on February 25, 2020 February 10, 2020 Aclaris Therapeutics to Present at the SVB Leerink 9th Annual Global Healthcare Conference January 9, 2020 Aclaris Therapeutics Announces Positive Results From Phase 1 Single and Multiple Ascending Dose Trial of ATI-450, an Investigational Oral MK2 Inhibitor View all » Events Feb 27, 202010:00 AM EST Aclaris Therapeutics, Inc. at SVB Leerink 9th Annual Global Healthcare Conference Feb 25, 20205:00 PM EST Q4 2019 Aclaris Therapeutics Inc. Earnings Conference Call Dec 4, 20193:05 PM EST Aclaris Therapeutics, Inc. at Evercore ISI 2nd Annual HealthCONx Conference View all » Feature presentation More presentations coming soon.
February 19, 2020 Aclaris Therapeutics to Announce Fourth Quarter and Full Year 2019 Financial Results on February 25, 2020
February 10, 2020 Aclaris Therapeutics to Present at the SVB Leerink 9th Annual Global Healthcare Conference
January 9, 2020 Aclaris Therapeutics Announces Positive Results From Phase 1 Single and Multiple Ascending Dose Trial of ATI-450, an Investigational Oral MK2 Inhibitor
Feb 27, 202010:00 AM EST Aclaris Therapeutics, Inc. at SVB Leerink 9th Annual Global Healthcare Conference
